Keywords
Biography
Cross-disciplinary researcher applying artificial intelligence and biomedical science to unravel complex, hard-to-solve problems - from infectious diseases to neuroimmunology. Skills include big data engineering, data science, machine learning, informatics, pharmacology and immunology.
My Grants
- Medicines Research Futures Fund Grant (2025; AUD $750K)
- UNSW Research Infrastructure Grant (2025; AUD $150K)
- New South Wales Ministry of...view more
Cross-disciplinary researcher applying artificial intelligence and biomedical science to unravel complex, hard-to-solve problems - from infectious diseases to neuroimmunology. Skills include big data engineering, data science, machine learning, informatics, pharmacology and immunology.
My Grants
- Medicines Research Futures Fund Grant (2025; AUD $750K)
- UNSW Research Infrastructure Grant (2025; AUD $150K)
- New South Wales Ministry of Health Grant (2024; AUD $100K)
My Qualifications
- Doctor of Philosophy (Medicine/Data Science)
University of New South Wales | Sydney, Australia | 2023
- Master of Public Health (Biostatistics/Epidemiology)
Curtin University | Perth, Australia | 2018
- Bachelor of Science (Pharmacology/Immunology)
University of New South Wales | Sydney, Australia | 2012
My Awards
|
2024 |
Kirby Institute Emerging Investigator Award |
|
2023 |
University of New South Wales Dean’s Award for Outstanding Thesis |
|
2023 |
Elsevier Atlas Award Winner Theme Sustainable Development Goal (SDG3), Good Health and Well-Being Publication |
|
2023 |
Kirby Institute Post-Graduate Student Prize |
|
2022 |
Top Ranked Abstract in Clinical Research- International Network on Hepatitis in Substance Users Conference, Glasgow, UK |
|
2022 |
Best presentation by STAToSPHERE conference, Sydney Australia |
My Research Activities
Neuroimmunology including post-viremic Illness (e.g. long COVID, CFS, ME) research applying novel machine learning methods to multi-dimensional clinical datasets. Leads Pharmaco-AI Infectious Disease Surveillance (PHASE) project aiming to enhance capabilities to monitor infectious disease trends, outcomes and health system utilisation in Australia. PHASE harnesses recent advances in national data-linkage and artificial intelligence to develop advanced pharmacoepidemiologic surveillance systems.